There are around 152,000 to 155,000 cases of urinary tract infection a year in Germany.1 In hospitals and care facilities these often occur following catheterisation. A preventive approach is important for avoiding hospital-acquired urinary tract infections caused by transurethral catheters. Find out about the different types of catheter and preventive measures.
Urinary tract infections are among the most widespread of hospital-acquired infections, accounting for over 20 percent alongside postoperative wound infections and infections of the lower respiratory tract such as pneumonia2,3 In non-surgical specialties, urinary tract infections are actually the most common type of hospital-acquired infection.4 Hospital-acquired urinary tract infections can be acquired in the hospital itself or shortly after hospitalisation.
Around 80 percent of hospital-acquired urinary tract infections are catheter-associated.2 15 to 25 percent of all patients have a catheter placed during their hospital stay, and the percentage is even higher in intensive care units.3 As these figures show, the issue is relevant for all hospital personnel.
Uncomplicated urinary tract infections are also among the most common outpatient infections5 and pose a risk to individuals self-catheterising at home.
The term “urinary tract infection” refers to inflammations of the urinary tract. They are mainly caused by bacteria. The main cause of uncomplicated urinary tract infections (77%) is gram-negative E.coli bacteria. Gram-positive bacteria such as Staphylococcus aureus and other staphylococci can also trigger the infections.6
There is a higher risk of infection in patients who
Most hospital-acquired urinary tract infections occur after diagnostic or therapeutic measures such as catheterisation in the lower urinary tract.1 Infections are generally triggered by endogenous bacteria in the gastrointestinal tract, urogenital tract and the perianal region.2
In some circumstances, however, hospital-acquired urinary tract infections can also be caused by exogenous pathogens. There are four main causes of catheter-associated urinary tract infections:7,8
If a catheter-associated urinary tract infection remains undetected the pathogens may continue to spread and cause inflammation of the renal pelvis (pyelonephritis) or in the worst case sepsis.7,8 Placing the catheter thus requires constant care and attention: Thorough disinfection of the genital area prior to inserting the catheter with mucous membrane antiseptics such as octenisept® is extremely important for preventing infection.
Infection control in catheterisation
The use of octenisept® before inserting a single-use or permanent catheter can significantly reduce the risk of hospital-acquired urinary tract infections.
You should always follow three basic principles to keep the risk of infection as low as possible as part of a prevention strategy:
Bladder catheters are used for both diagnostic and therapeutic purposes. They can be divided:
There are a number of different indications for placing a bladder catheter, from monitoring renal function, for urinary retention or post-operative care after major surgery such as a prostatectomy. For this reason treating physicians must make case-by-case decisions for all of their patients.
Transurethral catheters are inserted slowly through the urethra until they reach the bladder. They are classified into two types depending on how long they remain in the bladder:9
These are only suitable for one-off urine drainage or sampling and only remain in the bladder for a few minutes. Once the procedure has been completed the single-use catheter (made of PVC in most cases) must be removed.
These are normally made of latex, polyurethane or silicone. Permanent catheters allow urine to be drained from the bladder continuously over a prolonged period. Depending on the material and the indication the catheter is left in situ for a maximum of five days or up to three weeks.
Permanent catheters are predominantly used if there is a high risk of urinary retention recurring, further treatments or surgery are required. Single-use catheters and intermittent catheters can also be placed by the patients themselves (self-catheterisation), unlike permanent catheters. Patients must be instructed by a profession in how to self-catheterise.
The German KRINKO (the Commission for Hospital Hygiene and Infection Prevention) states that single-use catheters should always be chosen over permanent catheters whenever possible.10
Single-use catheterisation takes place around six times a day as needed.11 A special catheter set is required for both self-catheterisation and catheterisation by a member of staff.
Alternatively, a permanent catheter may also be used.
Hygiene has utmost priority when placing the catheter. Disinfection is therefore particularly important: An antiseptic mucous membrane disinfectant such as octenisept® is essential for disinfecting the outer genital area, as well as a suitable hand disinfectant such as desmanol®.
Other consumables may be used depending on the type of catheterisation.
Some patients prefer self-catheterisation Instructions for self-catheterisation to catheterisation by medical personnel External catheterisation as it allows them to remain or return to being mobile, independent and able to live without assistance.12
Important user information
octenisept® Active substances: octenidine dihydrochloride, phenoxyethanol (Ph.Eur.). Composition: 100 g solution contain: 0.1 g octenidine dihydrochloride, 2.0 g phenoxyethanol (Ph.Eur.). Other ingredients: cocamidopropylbetaine, sodium D gluconate, glycerol 85%, sodium chloride, sodium hydroxide, purified water. Indications: For repeated, short-term antiseptic treatment of mucous membranes and adjacent tissues prior to diagnostic and surgical procedures - in the ano-genital region including the vagina, vulva and glans penis as well as prior to bladder catheterization - in the oral cavity. For short-term supporting therapy of interdigital mycotic infections and adjuvant antiseptic wound treatment. Contraindications: octenisept® may not be used in cases of hypersensitivity to any of the components of the preparation. octenisept® should not be used for rinsing the abdominal cavity (e.g. intra-operatively) or the bladder, nor the tympanic membrane. Undesirable effects: rare: burning, redness, itching and warmth at the application site, very rare: allergic contact reaction, e.g. temporary redness at the application site; frequency unknown: after lavage of deep wounds with a syringe, persistent edema, erythema and also tissue necrosis have been reported, in some cases requiring surgical revision. Rinsing of the oral cavity may cause a transitory bitter sensation. Revision 11/22
To prevent possible tissue injury, the product must not be injected into the deep tissue using a syringe. The product is intended for superficial use only (application by swab or spray pump).
Schülke & Mayr GmbH, 22840 Norderstedt, Germany, Tel. +49 40 52100-666, firstname.lastname@example.org
1 Bundesverband Medizintechnologie e. V. Hintergrundinformationen Harnwegsinfektionen. Presentation at https://www.krankenhausinfektionen.info/ki-de/kikrankenhaus-infektionen/harnwegsinfektionen. Accessed on August 22, 2022.
2 „Prävention und Kontrolle Katheter-assoziierter Harnwegsinfektionen: Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut“. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, Bd. 58, Nr. 6, 2015, S. 641–650, doi:10.1007/s00103-015-2152-3. Accessed on August 23, 2022.
3 Deutscher Ärzteverlag GmbH. “Katheter-assoziierte Harnwegsinfektionen bei erwachsenen Patienten”. Deutsches Ärzteblatt, https://www.aerzteblatt.de/archiv/212331/Katheter-assoziierte-Harnwegsinfektionen-bei-erwachsenen-Patienten. Accessed on August 22, 2022.
4 “Harnwegsinfektionen”. Krankenhausinfektionen.info, https://www.krankenhausinfektionen.info/ki-de/kikrankenhaus-infektionen/harnwegsinfektionen. Accessed on August 22, 2022.
5 Deutscher Ärzteverlag GmbH. “Unkomplizierte Harnwegsinfektionen”. Deutsches Ärzteblatt, https://www.aerzteblatt.de/archiv/93815/Unkomplizierte-Harnwegsinfektionen. Accessed on November 1st, 2022
6 Manski, Med Dirk. “Harnwegsinfektion: Ursachen, Bakterien und Risikofaktoren”. Urologielehrbuch.de, https://www.urologielehrbuch.de/harnwegsinfektion_ursachen.html. Accessed on August 25, 2022.
7 Bundesverband Medizintechnologie e. V. Harnwegsinfektionen beim Mann. Presentation at https://www.krankenhausinfektionen.info/ki-de/kikrankenhaus-infektionen/harnwegsinfektionen. Accessed on August 22, 2022.
8 Bundesverband Medizintechnologie e. V. Harnwegsinfektionen bei der Frau. Presentation at https://www.krankenhausinfektionen.info/ki-de/kikrankenhaus-infektionen/harnwegsinfektionen. Accessed on August 22, 2022.
9 “Den Abfluss erleichtern”. DAZ.online, December 10, 2015, https://www.deutsche-apotheker-zeitung.de/daz-az/2015/daz-50-2015/den-abfluss-erleichtern. Accessed on August 23, 2022.
10 Simon, Arne, u. a. “Katheterassoziierte Harnwegsinfektionen – neue KRINKO-Empfehlung zur Prävention”. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, Vol. 58, no. 6, 2015, pp. 515–518, doi:10.1007/s00103-015-2139-0. Accessed on August 23, 2022.
11 Bremer, J., u. a. “Objektiver und subjektiver Hilfsmittelbedarf bei Patienten mit neurogenen Harnblasenfunktionsstörungen: Multicenterstudie zur Ermittlung des täglichen Bedarfs an urologischen Hilfsmitteln”. Der Urologe. Ausg. A, Bd. 55, Nr. 12, 2016, S. 1553–1563, doi:10.1007/s00120-016-0250-y. Zugegriffen 23. August 2022.
12 “Urologenportal: Selbstkatheterismus: So können Patienten Harnwegsinfekte vermeiden”. Urologenportal.de, https://www.urologenportal.de/ass-selbstkatheterismus.html. Accessed on August 23, 2022.